Showing results (101-110 of 115) with videos related to
Sort By:
Pageof 12
Plos One|July 25, 2020
Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruptionNeeda A Virani, Olivia J Kelada, Sijumon Kunjachan, et al.Cancer Medicine|September 19, 2025
The Therapeutic Potential of Photoimmunotherapy as a Safe, Effective and Non-Toxic Treatment Option for Superficial Triple Negative Breast CancerFleury Augustin Nsole Biteghe, Neelakshi Mungra, Zaria Malindi, et al.The Journal of Molecular Diagnostics : JMD|August 11, 2007
DNA degradation test predicts success in whole-genome amplification from diverse clinical samplesFengfei Wang, Lilin Wang, Christine Briggs, et al.Clinical Chemistry|January 3, 2025
Impact of Higher Cell-Free DNA Yields on Liquid Biopsy Testing in Glioblastoma PatientsJ Bryan Iorgulescu, Timothy Blewett, Kan Xiong, et al.Nature Communications|April 11, 2020
Author Correction: Image-guided radiotherapy platform using single nodule conditional lung cancer mouse modelsGrit S Herter-Sprie, Houari Korideck, Camilla L Christensen, et al.Nature Communications|December 19, 2014
Image-guided radiotherapy platform using single nodule conditional lung cancer mouse modelsGrit S Herter-Sprie, Houari Korideck, Camilla L Christensen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck CancerEdward S Sim, Justin Rhoades, Kan Xiong, et al.Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Immediate postoperative minimal residual disease detection with MAESTRO predicts recurrence and survival in head and neck cancer patients treated with surgeryEdward S Sim, Justin Rhoades, Kan Xiong, et al.Oncotarget|December 5, 2015
Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical modelMark Duquette, Peter M Sadow, Amjad Husain, et al.Nature Biomedical Engineering|March 18, 2022
Massively parallel enrichment of low-frequency alleles enables duplex sequencing at low depthGregory Gydush, Erica Nguyen, Jin H Bae, et al.Pageof 12